A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

The recombinant zoster vaccine protects against HZ and PHN in older patients with RA, with no increased risk for RA flares found within 30 days of vaccination.

G etting vaccinated for the viral illness shingles, which causes a painful rash, could potentially be the next best tool in ...

The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...

Most people know that exercising, eating healthy and keeping your mind active can lower your risk of dementia. But with the ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be ...

Analysis of a Welsh program offering live-attenuated shingles vaccines to people born after a certain date showed a 20 percent relative drop in dementia risk.

A large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The ...

In 2024, a study of 200,000 U.S. older adults showed the recombinant subunit zoster vaccine (Shingrix) was associated with a larger reduction in dementia risk than the live zoster vaccine.

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

Recent estimates suggest that about 7.4% of adults over 60 or 88 lakh people are living with dementia in India.